Ozempic Butt: a side effect of weight-loss Drugs

"Image of a person holding their waistline, highlighting the concept of Ozempic Butt as a side effect of weight loss drugs

introduction: The use of semaglutide, marketed under the names Ozempic and Wegovy, as a weight-loss tool has gained popularity due to its appetite-suppressing properties. However, some people have reported experiencing a side effect known as “Ozempic Butt”, characterized by sagging skin and reduced elasticity in certain areas of the body. This article explores the “Ozempic … Read more

Ketamine for Childhood Depression Treatment

A child receiving ketamine therapy, a potential treatment for childhood depression.

introduction: Children have received ketamine safely in medical settings for a significant period, underscoring the drug’s established safety record and its potential for conducting extensive clinical trials. The safety profile of ketamine in pediatric use Ketamine, despite its reputation, has been widely utilized in pediatric medical settings, demonstrating an outstanding safety profile. Medical practitioners have … Read more

Abdominal Aortic Aneurysm: Anatomy and Risks

"Influence of COVID-19 on Abdominal Aortic Aneurysm Growth"

Introduction The link between COVID-19 and the management of abdominal aortic aneurysms (AAA) is revealed by ground-breaking research at the Scientific Sessions 2023 of the American Heart Association’s Vascular Discovery: From Genes to Medicine conference. The possible effect of earlier COVID-19 infection on the quick development of these risky bulges is examined in noteworthy research. … Read more

Gene Therapy Offers Hope for Inherited Blindness: Expert Jean Bennett Shares Insights

Gene Therapy Offers Hope for Inherited Blindness

A revolutionary medical procedure called gene therapy gives those with hereditary blindness fresh hope. Clinical studies are also being conducted to expand these therapies to treat additional diseases. Recent scientific advancements have shown techniques to treat various types of blindness using gene therapy. The development of gene therapy medications for hereditary eye illnesses is being … Read more

USC Researchers Identify Biomarker for Chemoimmunotherapy Treatment Response in NSCLC Patients

Treatment Response in NSCLC Patients

Researchers at the USC Norris Comprehensive Cancer Center have identified a biomarker called CX3CR1 that may be able to predict a patient’s response to chemotherapy and immunotherapy. Six to nine weeks after the patient begins therapy, a straightforward blood test can identify the biomarker, which is expressed on T-cells. After six and nine weeks of … Read more